NAFARELIN ACETATE

NAFARELIN ACETATE was reported 273 times

NAFARELIN ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHOLANGIOSARCOMA 2 0.2500
1 CRYOFIBRINOGENAEMIA 1 0.1250
2 VASCULAR DISSECTION 2 0.0625
3 VULVOVAGINAL ADHESION 2 0.0571
4 VAGINAL OBSTRUCTION 1 0.0556
5 HAEMATOCOLPOS 1 0.0312
6 OVARIAN ABSCESS 4 0.0256
7 BASILAR ARTERY THROMBOSIS 4 0.0222
8 OOPHORITIS 3 0.0211
9 OVARIAN HYPERSTIMULATION SYNDROME 48 0.0206
10 VERTEBRAL ARTERY DISSECTION 4 0.0196
11 ADNEXAL TORSION 6 0.0189
12 HYPOTHALAMO-PITUITARY DISORDERS 1 0.0154
13 BIOCHEMICAL PREGNANCY 1 0.0093
14 PELVIC FLUID COLLECTION 6 0.0085
15 MENSTRUAL DISCOMFORT 1 0.0083
16 UMBILICAL CORD PROLAPSE 1 0.0081
17 RHINOPLASTY 1 0.0076
18 ENDOMETRIAL ATROPHY 1 0.0069
19 PERITONEAL HAEMATOMA 1 0.0067
20 THYROID PAIN 1 0.0056
21 ENDOMETRIAL ABLATION 2 0.0056
22 BLOOD KETONE BODY PRESENT 1 0.0053
23 FAILURE TO SUSPEND MEDICATION 1 0.0048
24 CYST RUPTURE 3 0.0044
25 VAGINAL PAIN 1 0.0044
26 OVARIAN CYST RUPTURED 5 0.0039
27 EFFUSION 5 0.0037
28 EXPRESSIVE LANGUAGE DISORDER 1 0.0035
29 PROGESTERONE DECREASED 1 0.0032
30 EXPOSURE TO ALLERGEN 1 0.0031
31 OESTRADIOL DECREASED 1 0.0031
32 GRANULOMATOUS LIVER DISEASE 2 0.0028
33 VAGINAL FISTULA 1 0.0028
34 OVARIAN ENLARGEMENT 1 0.0026
35 CAPILLARY DISORDER 1 0.0026
36 ENDOMETRIAL HYPERTROPHY 1 0.0025
37 PELVIC HAEMATOMA 1 0.0023
38 IMPLANT SITE REACTION 1 0.0022
39 ANTI-THYROID ANTIBODY POSITIVE 1 0.0022
40 BONE DEBRIDEMENT 1 0.0021
41 WAIST CIRCUMFERENCE INCREASED 2 0.0019
42 OVARIAN FAILURE 1 0.0019
43 ERYTHEMA NODOSUM 6 0.0017
44 BLOOD OESTROGEN INCREASED 1 0.0017
45 THYROID CYST 1 0.0017
46 ADENOCARCINOMA OF COLON 3 0.0016
47 DRUG LEVEL CHANGED 1 0.0016
48 SEQUESTRECTOMY 1 0.0015
49 ENDOMETRIOSIS 7 0.0015
50 OPHTHALMIC MIGRAINE 1 0.0014
51 EYE ROLLING 1 0.0014
52 PLACENTA PRAEVIA 1 0.0013
53 LIMB MALFORMATION 1 0.0013
54 ENDOMETRIAL HYPERPLASIA 1 0.0012
55 SUPERFICIAL VEIN THROMBOSIS 1 0.0012
56 UTERINE HAEMORRHAGE 5 0.0012
57 MENOPAUSE 3 0.0012
58 INCORRECT STORAGE OF DRUG 2 0.0012
59 GENITAL BURNING SENSATION 1 0.0012
60 JUGULAR VEIN THROMBOSIS 2 0.0011
61 PRIMARY SEQUESTRUM 1 0.0011
62 DRUG EXPOSURE BEFORE PREGNANCY 1 0.0010
63 VULVOVAGINAL DISCOMFORT 4 0.0009
64 OVARIAN CYST 9 0.0009
65 ESSENTIAL TREMOR 1 0.0009
66 STRESS AT WORK 1 0.0009
67 INTRA-ABDOMINAL HAEMORRHAGE 2 0.0008
68 BRONCHIAL HYPERREACTIVITY 1 0.0008
69 PERITONEAL HAEMORRHAGE 1 0.0007
70 PRECANCEROUS CELLS PRESENT 1 0.0007
71 INVESTIGATION ABNORMAL 1 0.0007
72 ASCITES 18 0.0006
73 ANTIBODY TEST POSITIVE 1 0.0006
74 DEAFNESS BILATERAL 1 0.0006
75 MENOMETRORRHAGIA 1 0.0005
76 OSTEOPOROTIC FRACTURE 1 0.0005
77 CLEFT PALATE 1 0.0005
78 VENOUS THROMBOSIS LIMB 1 0.0005
79 MENSTRUAL DISORDER 4 0.0005
80 BLOOD TESTOSTERONE INCREASED 1 0.0005
81 DEREALISATION 1 0.0005
82 LICHENOID KERATOSIS 1 0.0004
83 UMBILICAL HERNIA 2 0.0004
84 METASTASIS 3 0.0004
85 URINARY HESITATION 1 0.0004
86 STARING 1 0.0004
87 ORAL INTAKE REDUCED 1 0.0004
88 EYE OEDEMA 1 0.0004
89 VENOOCCLUSIVE DISEASE 1 0.0004
90 RETINAL ARTERY OCCLUSION 1 0.0004
91 BREAST SWELLING 1 0.0004
92 BLOOD PHOSPHORUS INCREASED 1 0.0004
93 MUSCLE TWITCHING 8 0.0003
94 BLOOD BLISTER 1 0.0003
95 BLOOD CREATININE DECREASED 1 0.0003
96 VULVOVAGINAL DRYNESS 1 0.0003
97 OLIGOHYDRAMNIOS 1 0.0003
98 MATERNAL EXPOSURE BEFORE PREGNANCY 2 0.0003
99 DIFFICULTY IN WALKING 1 0.0003
100 FACIAL PARESIS 1 0.0003
101 PYODERMA GANGRENOSUM 1 0.0003
102 UTERINE LEIOMYOMA 2 0.0003
103 BLINDNESS TRANSIENT 2 0.0003
104 NEURODERMATITIS 1 0.0003
105 GINGIVAL DISORDER 1 0.0003
106 VENOUS THROMBOSIS 1 0.0003
107 MENORRHAGIA 5 0.0003
108 ABORTION SPONTANEOUS 10 0.0002
109 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
110 HOMICIDAL IDEATION 1 0.0002
111 PERIPHERAL ISCHAEMIA 1 0.0002
112 GOITRE 1 0.0002
113 DEMYELINATION 1 0.0002
114 SUICIDAL BEHAVIOUR 1 0.0002
115 PRODUCT DISPENSING ISSUE 1 0.0002
116 TEARFULNESS 1 0.0002
117 AMENORRHOEA 4 0.0002
118 GROIN PAIN 2 0.0002
119 URINARY TRACT DISORDER 1 0.0002
120 FEELING OF DESPAIR 1 0.0002
121 ANOSMIA 3 0.0002
122 STILLBIRTH 1 0.0002
123 HORMONE LEVEL ABNORMAL 1 0.0002
124 ABDOMINAL PAIN LOWER 5 0.0002
125 DYSPHORIA 1 0.0002
126 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
127 MENINGIOMA 3 0.0002
128 PARTIAL SEIZURES 1 0.0002
129 ANAL FISTULA 1 0.0002
130 ANAL FISSURE 1 0.0002
131 AUTISM SPECTRUM DISORDER 1 0.0002
132 INTRACRANIAL PRESSURE INCREASED 1 0.0002
133 HYPERVENTILATION 1 0.0002
134 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
135 SCOLIOSIS 1 0.0002
136 SWELLING OF EYELID 1 0.0002
137 PHOTOPSIA 1 0.0002
138 INCOHERENT 1 0.0002
139 PREGNANCY 3 0.0001
140 HYPERTHYROIDISM 2 0.0001
141 DERMATITIS BULLOUS 1 0.0001
142 MAJOR DEPRESSION 1 0.0001
143 HYDRONEPHROSIS 1 0.0001
144 DEPRESSED MOOD 7 0.0001
145 APHTHOUS ULCER 1 0.0001
146 NASAL DISCOMFORT 1 0.0001
147 GINGIVAL PAIN 1 0.0001
148 AGEUSIA 3 0.0001
149 HOT FLUSH 9 0.0001
150 PRODUCT CONTAINER ISSUE 1 0.0001
151 HYSTERECTOMY 1 0.0001
152 PRODUCT COMMUNICATION ISSUE 1 0.0001
153 GASTROINTESTINAL INFECTION 1 0.0001
154 PELVIC PAIN 2 0.0001
155 CRYING 4 0.0001
156 MOOD ALTERED 3 0.0001
157 BRAIN NEOPLASM 1 0.0001
158 DYSGEUSIA 8 0.0001
159 AFFECT LABILITY 1 0.0001
160 HEPATOMEGALY 1 0.0001
161 POOR QUALITY DEVICE USED 1 0.0001
162 VAGINAL DISCHARGE 1 0.0001
163 MOTOR DYSFUNCTION 1 0.0001
164 HYPERBILIRUBINAEMIA 1 0.0001
165 MOOD SWINGS 3 0.0001
166 BREAST PAIN 1 0.0001
167 NIGHT SWEATS 3 0.0001
168 MENSTRUATION DELAYED 1 0.0001
169 URINARY RETENTION 3 0.0001
170 OCULAR DISCOMFORT 1 0.0001
171 PANCREATITIS ACUTE 2 0.0001
172 FISTULA 1 0.0001
173 NEOPLASM 1 0.0001
174 ABDOMINAL DISTENSION 9 0.0001
175 ATAXIA 1 0.0001
176 CEREBRAL INFARCTION 2 0.0001
177 CYST 1 0.0001
178 TOOTH EXTRACTION 1 0.0001
179 DERMATITIS ALLERGIC 1 0.0001
180 INCORRECT PRODUCT STORAGE 1 0.0001
181 ORAL CANDIDIASIS 1 0.0001
182 EYE HAEMORRHAGE 1 0.0001
183 UVEITIS 1 0.0001
184 DRUG TOXICITY 1 0.0001
185 GINGIVAL BLEEDING 1 0.0001
186 OSTEOPOROSIS 3 0.0001
187 PROCEDURAL PAIN 2 0.0001
188 HUNGER 1 0.0001
189 VAGINAL HAEMORRHAGE 3 0.0001
190 GASTROENTERITIS 1 0.0001
191 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
192 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
193 BONE LOSS 1 0.0001
194 IRRITABILITY 4 0.0001
195 APHASIA 2 0.0001
196 OSTEOPENIA 1 0.0001
197 PLEURAL EFFUSION 4 0.0001
198 DEVICE FAILURE 1 0.0001
199 EPILEPSY 2 0.0001
200 EXPOSURE DURING PREGNANCY 4 0.0001
201 NERVOUS SYSTEM DISORDER 2 0.0001
202 CYANOSIS 1 0.0001
203 ARRHYTHMIA 3 0.0001
204 SENSORY DISTURBANCE 1 0.0001
205 MULTIPLE FRACTURES 1 0.0001
206 EYE DISORDER 2 0.0001
207 CANDIDA INFECTION 1 0.0001
208 ANGER 2 0.0001
209 METRORRHAGIA 1 0.0001
210 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
211 GASTRIC DISORDER 2 0.0001
212 HAEMORRHAGE 6 0.0001
213 LOCAL SWELLING 1 0.0001
214 HYPERGLYCAEMIA 2 0.0001
215 BONE DISORDER 1 0.0001
216 SWELLING 5 0.0001
217 DYSARTHRIA 2 0.0001
218 FRACTURE 1 0.0001
219 MUSCULOSKELETAL DISORDER 1 0.0001
220 CONVULSION 3 0.0001
221 MIGRAINE 5 0.0001
222 POST PROCEDURAL COMPLICATION 1 0.0001
223 ABDOMINAL PAIN 12 0.0001
224 EAR PAIN 1 0.0001
225 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
226 NASAL CONGESTION 3 0.0001
227 INTENTIONAL SELF-INJURY 1 0.0000
228 BODY TEMPERATURE INCREASED 1 0.0000
229 MOUTH ULCERATION 1 0.0000
230 OSTEOARTHRITIS 2 0.0000
231 AMNESIA 3 0.0000
232 SNEEZING 1 0.0000
233 SUICIDAL IDEATION 4 0.0000
234 CONDITION AGGRAVATED 13 0.0000
235 MENTAL IMPAIRMENT 1 0.0000
236 NEURALGIA 1 0.0000
237 VISUAL IMPAIRMENT 5 0.0000
238 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
239 UNRESPONSIVE TO STIMULI 1 0.0000
240 RASH GENERALISED 1 0.0000
241 ANHEDONIA 1 0.0000
242 MENSTRUATION IRREGULAR 1 0.0000
243 FEAR 1 0.0000
244 FREQUENT BOWEL MOVEMENTS 1 0.0000
245 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
246 VISION BLURRED 5 0.0000
247 RESPIRATORY DISTRESS 1 0.0000
248 ARTHROPATHY 2 0.0000
249 HAEMOPTYSIS 1 0.0000
250 ANGINA PECTORIS 1 0.0000
251 PALPITATIONS 4 0.0000
252 BONE PAIN 2 0.0000
253 SURGERY 2 0.0000
254 PSYCHOTIC DISORDER 1 0.0000
255 DYSPNOEA 19 0.0000
256 HEPATIC FAILURE 1 0.0000
257 EMOTIONAL DISORDER 1 0.0000
258 SWOLLEN TONGUE 1 0.0000
259 PARAESTHESIA 5 0.0000
260 SWELLING FACE 2 0.0000
261 OSTEONECROSIS 1 0.0000
262 DRUG DOSE OMISSION 5 0.0000
263 VISUAL ACUITY REDUCED 1 0.0000
264 SKIN DISORDER 1 0.0000
265 ABDOMINAL DISCOMFORT 5 0.0000
266 TYPE 2 DIABETES MELLITUS 1 0.0000
267 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
268 HAEMATURIA 1 0.0000
269 SLEEP DISORDER 2 0.0000
270 LYMPHADENOPATHY 1 0.0000
271 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
272 CEREBRAL HAEMORRHAGE 1 0.0000
273 RESTLESSNESS 1 0.0000
274 HYPERSENSITIVITY 5 0.0000
275 EYE SWELLING 1 0.0000
276 EPISTAXIS 2 0.0000
277 DYSPNOEA EXERTIONAL 1 0.0000
278 DEPRESSION 6 0.0000
279 INSOMNIA 7 0.0000
280 DRUG DOSE OMISSION BY DEVICE 2 0.0000
281 ABNORMAL BEHAVIOUR 1 0.0000
282 DRUG INTERACTION 4 0.0000
283 MALAISE 11 0.0000
284 FEELING ABNORMAL 6 0.0000
285 COMPLETED SUICIDE 2 0.0000
286 RENAL FAILURE ACUTE 1 0.0000
287 HYPOACUSIS 1 0.0000
288 MENTAL DISORDER 1 0.0000
289 LIVER DISORDER 1 0.0000
290 TACHYCARDIA 2 0.0000
291 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
292 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
293 SKIN DISCOLOURATION 1 0.0000
294 HYPOKALAEMIA 1 0.0000
295 PAIN 13 0.0000
296 OCULAR HYPERAEMIA 1 0.0000
297 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
298 HEADACHE 13 0.0000
299 DIARRHOEA 13 0.0000
300 AGGRESSION 1 0.0000
301 HAEMOGLOBIN DECREASED 2 0.0000
302 PERIPHERAL SWELLING 3 0.0000
303 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
304 MUSCULOSKELETAL PAIN 1 0.0000
305 SPEECH DISORDER 1 0.0000
306 DISTURBANCE IN ATTENTION 1 0.0000
307 HAEMATOCHEZIA 1 0.0000
308 MEDICATION ERROR 1 0.0000
309 URTICARIA 3 0.0000
310 NECK PAIN 1 0.0000
311 WEIGHT INCREASED 4 0.0000
312 BLISTER 1 0.0000
313 EYE PAIN 1 0.0000
314 ASTHMA 2 0.0000
315 SUICIDE ATTEMPT 1 0.0000
316 STOMATITIS 1 0.0000
317 NAUSEA 13 0.0000
318 FEELING HOT 1 0.0000
319 PRODUCT USE ISSUE 3 0.0000
320 INTENTIONAL OVERDOSE 1 0.0000
321 DEVICE EXPULSION 1 0.0000
322 BLOOD PRESSURE DECREASED 1 0.0000
323 OFF LABEL USE 13 0.0000
324 PRODUCT QUALITY ISSUE 2 0.0000
325 OVERDOSE 3 0.0000
326 PAIN IN EXTREMITY 4 0.0000
327 INCORRECT DOSE ADMINISTERED 3 0.0000
328 BLOOD PRESSURE INCREASED 2 0.0000
329 FATIGUE 10 0.0000
330 ARTHRITIS 1 0.0000
331 THROMBOSIS 1 0.0000
332 DRY MOUTH 1 0.0000
333 SKIN EXFOLIATION 1 0.0000
334 CEREBROVASCULAR ACCIDENT 2 0.0000
335 MYALGIA 2 0.0000
336 INTENTIONAL PRODUCT MISUSE 1 0.0000
337 GASTROINTESTINAL DISORDER 1 0.0000
338 COUGH 3 0.0000
339 CARDIAC DISORDER 1 0.0000
340 VOMITING 5 0.0000
341 DYSPHAGIA 1 0.0000
342 NEUROPATHY PERIPHERAL 1 0.0000
343 SYNCOPE 1 0.0000
344 FLUSHING 1 0.0000
345 ABDOMINAL PAIN UPPER 2 0.0000
346 CONSTIPATION 2 0.0000
347 INFLUENZA 1 0.0000
348 MUSCULAR WEAKNESS 1 0.0000
349 DECREASED APPETITE 2 0.0000
350 BACK PAIN 2 0.0000
351 CHILLS 1 0.0000
352 DISEASE PROGRESSION 1 0.0000
353 DRUG INEFFECTIVE 11 0.0000
354 DIZZINESS 4 0.0000
355 HYPERHIDROSIS 1 0.0000
356 NEUTROPENIA 1 0.0000
357 MEMORY IMPAIRMENT 1 0.0000
358 ARTHRALGIA 3 0.0000
359 WEIGHT DECREASED 2 0.0000
360 ANXIETY 2 0.0000
361 RASH 3 0.0000
362 HYPOAESTHESIA 1 0.0000
363 TREMOR 1 0.0000
364 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
365 CHEST PAIN 1 0.0000
366 ASTHENIA 2 0.0000
367 ANAEMIA 1 0.0000
368 GAIT DISTURBANCE 1 0.0000
369 ALOPECIA 1 0.0000
370 SOMNOLENCE 1 0.0000
371 ERYTHEMA 1 0.0000
372 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
373 PRODUCT DOSE OMISSION ISSUE 1 0.0000
374 FALL 1 0.0000
375 PYREXIA 1 0.0000
376 PRURITUS 1 0.0000